Charles Theuer, President and CEO at Tracon Pharmaceuticals, Inc. (TCON), bought 4,000 shares at $3.41 ($14K) on 2021-11-05, disclosed to the SEC on 2021-11-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.41 | 1,000 | $3K | 24.9% |
| 2 | $3.42 | 3,000 | $10K | 75.1% |
| Total | $3.42 avg | 4,000 | $14K | 100% |
| Filing → |
| TCON | BUY | 2023-01-19 | $11K | — | Filing → |
| TCON | BUY | 2022-12-15 | $30K | — | Filing → |
| TCON | BUY | 2022-11-22 | $20K | — | Filing → |